Skip to main content

Advertisement

SpringerLink
Log in

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

  • Ischemic Heart Disease (D Mukherjee, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The aims of this review are to summarize recent data on mortality and cardiovascular disease (CVD) in type 1 and type 2 diabetes and to determine the interventions that could have contributed to a reduction in mortality.

Recent Findings

Recent studies found a downward trend in mortality and CVD among both diabetics and non-diabetics worldwide over the last few decades. The decline among diabetics is steeper than that among non-diabetics. Despite a parallel trend of decline, an approximately twofold difference in mortality and CVD between the two populations remains.

Summary

A greater emphasis on glycemic control, management of cardiovascular risk factors, quality improvement programs, and advances in treatment of conditions associated diabetes are the factors that potentially contributed to the improvement. Although the trend is encouraging, a rising prevalence of diabetes will continue the absolute disease burden to the society. Future interventions should focus on prevention of diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414–31.

    Article  CAS  Google Scholar 

  2. •• Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017. A periodic publication of the United States Centers for Disease Control and Prevention (CDC) that provides updated statistics about diabetes in the United States for a scientific audience.

  3. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44(Suppl 2):S14–21.

    Article  Google Scholar 

  4. Chaib F. New WHO statistics highlight increases in blood pressure and diabetes, other noncommunicable risk factors, 2012. World Health Organization: Noncommunicable Diseases and Mental Health.

  5. Vaidya V, Gangan N, Sheehan J. Impact of cardiovascular complications among patients with type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):487–97. https://doi.org/10.1586/14737167.2015.1024661.

    Article  PubMed  Google Scholar 

  6. Kovacic JC, Castellano JM, Farkouh ME, Fuster V. The relationships between cardiovascular disease and diabetes: focus on pathogenesis. Endocrinol Metab Clin N Am. 2014;43(1):41–57. https://doi.org/10.1016/j.ecl.2013.09.007.

    Article  Google Scholar 

  7. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–91. https://doi.org/10.1056/NEJMoa0706245.

    Article  CAS  PubMed  Google Scholar 

  8. Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet (London, England). 2012;379(9833):2252–61. https://doi.org/10.1016/s0140-6736(12)60480-2.

    Article  Google Scholar 

  9. •• Rawshani A, Rawshani A, Franzen S, Eliasson B, Svensson AM, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407–18. https://doi.org/10.1056/NEJMoa1608664 Trends in deaths and cardiovascular events among patients with type 1 diabetes and type 2 diabetes from the Swedish National Diabetes Register from 1998 to 2014 compared with matched controls.

    Article  PubMed  Google Scholar 

  10. •• Gregg EW, Cheng YJ, Srinivasan M, Lin J, Geiss LS, Albright AL, et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet (London, England). 2018;391(10138):2430–40. https://doi.org/10.1016/s0140-6736(18)30314-3 Trends in total mortality and cause-specific mortality, including cardiovascular mortality, among adults with diabetes from the US National Health Interview Survey Linked Mortality files from 1998–1994 through 2010–2015 compared with adults without diabetes.

    Article  Google Scholar 

  11. Dabelea D, Bell RA, D'Agostino RB Jr, Imperatore G, Johansen JM, Linder B, et al. Incidence of diabetes in youth in the United States. Jama. 2007;297(24):2716–24. https://doi.org/10.1001/jama.297.24.2716.

    Article  PubMed  Google Scholar 

  12. •• Secrest AM, Washington RE, Orchard TJ. Mortality trends in type 1 diabetes. Chapter 35, In Diabetes in America, 3rd ed. Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, Eds. Bethesda, MD, National Institutes of Health, NIH Pub No. 17–1468, 2018:35–1 – 35-16. A report published by the US National Institute of Diabetes and Digestive and Kidney Diseases, which analyzes mortality trends and investigates risk factors for a higher mortality in individuals with type 1 diabetes than general population.

  13. Diabetes death rates among youths aged </= 19 years--United States, 1968–2009. MMWR Morbidity and mortality weekly report. 2012;61(43):869–72.

  14. •• Petrie D, Lung TW, Rawshani A, Palmer AJ, Svensson AM, Eliasson B, et al. Recent trends in life expectancy for people with type 1 diabetes in Sweden. Diabetologia. 2016;59(6):1167–76. https://doi.org/10.1007/s00125-016-3914-7 Analysis of data from the Swedish National Diabetes Register linked with death records to assess trends in overall and cause-specific mortality for individuals with type 1 diabetes.

    Article  PubMed  Google Scholar 

  15. •• Rosenquist KJ, Fox CS. Chapter 36, In Diabetes in America, 3rd ed. In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Mortality trends in type 2 diabetes. Bethesda, MD: National Institutes of Health, NIH Pub No. 17–1468; 2018. p. 36–1–36-14. A report published by the US National Institute of Diabetes and Digestive and Kidney Diseases, which analyzes mortality trends and investigates risk factors for a higher mortality in individuals with type 2 diabetes than in general population.

    Google Scholar 

  16. Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med. 2007;147(3):149–55.

    Article  Google Scholar 

  17. Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB Sr, Savage PJ, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation. 2009;119(13):1728–35. https://doi.org/10.1161/circulationaha.108.829176.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Taylor KS, Heneghan CJ, Farmer AJ, Fuller AM, Adler AI, Aronson JK, et al. All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care. 2013;36(8):2366–71. https://doi.org/10.2337/dc12-1513.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. •• Bragg F, Holmes MV, Iona A, Guo Y, Du H, Chen Y, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China. Jama. 2017;317(3):280–9. https://doi.org/10.1001/jama.2016.19720 A population study that uses national survey data to compare the prevalence of diabetes and to provide estimates of the diabetes-related excess mortality for adults living in rural and urban areas of China.

    Article  PubMed  PubMed Central  Google Scholar 

  20. McEwen LN, Karter AJ, Waitzfelder BE, Crosson JC, Marrero DG, Mangione CM, et al. Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD). Diabetes Care. 2012;35(6):1301–9. https://doi.org/10.2337/dc11-2281.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Koek HL, Soedamah-Muthu SS, Kardaun JW, Gevers E, de Bruin A, Reitsma JB, et al. Short- and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus. Eur J Epidemiol. 2007;22(12):883–8. https://doi.org/10.1007/s10654-007-9191-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes. 2010;59(12):3216–22. https://doi.org/10.2337/db10-0862.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, et al. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med. 1999;16(6):459–65.

    Article  CAS  Google Scholar 

  24. •• Rawshani A, Sattar N, Franzen S, Rawshani A, Hattersley AT, Svensson AM, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet (London, England). 2018;392(10146):477–86. https://doi.org/10.1016/s0140-6736(18)31506-x A nationwide register-based cohort study in Sweden examining how age at diagnosis of type 1 diabetes relates to excess mortality and cardiovascular risk.

    Article  Google Scholar 

  25. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB Sr, et al. Trends in cardiovascular complications of diabetes. Jama. 2004;292(20):2495–9. https://doi.org/10.1001/jama.292.20.2495.

    Article  CAS  PubMed  Google Scholar 

  26. Booth GL, Kapral MK, Fung K, Tu JV. Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care. 2006;29(1):32–7.

    Article  Google Scholar 

  27. •• Tsujimoto T, Kajio H, Sugiyama T. Favourable changes in mortality in people with diabetes: US NHANES 1999–2010. Diabetes Obes Metab. 2018;20(1):85–93. https://doi.org/10.1111/dom.13039 Trends in total, cardiovascular, and cardiac mortality in diabetics participated in the US National Health and Nutrition Examination Survey during the period 2005 to 2010 and comparison with participants without diabetes.

    Article  PubMed  Google Scholar 

  28. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370(16):1514–23. https://doi.org/10.1056/NEJMoa1310799.

    Article  CAS  PubMed  Google Scholar 

  29. •• Burrows NR, Li Y, Gregg EW, Geiss LS. Declining rates of hospitalization for selected cardiovascular disease conditions among adults aged >/=35 years with diagnosed diabetes, U.S., 1998-2014. Diabetes Care. 2018;41(2):293–302. https://doi.org/10.2337/dc17-1259 Trend analyses of age-adjusted hospitalization rates for specific cardiovascular conditions using the National Inpatient Sample data of the US Agency for Healthcare Research and Quality.

    Article  PubMed  Google Scholar 

  30. •• Jung CH, Chung JO, Han K, Ko SH, Ko KS, Park JY. Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006–2013). Cardiovasc Diabetol. 2017;16(1):1. https://doi.org/10.1186/s12933-016-0482-6 Eight-year trend of cardiovascular disease in Korean adults with type 2 diabetes, aged 30 years and older, using data from four consecutive nationwide databases of Korean national health insurance service.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Kim HC, Oh SM. Noncommunicable diseases: current status of major modifiable risk factors in Korea. J Prev Med Public Health. 2013;46(4):165–72. https://doi.org/10.3961/jpmph.2013.46.4.165.

    Article  PubMed  PubMed Central  Google Scholar 

  32. •• de Miguel-Yanes JM, Jimenez-Garcia R, Hernandez-Barrera V, Mendez-Bailon M, de Miguel-Diez J, Lopez-de-Andres A. Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014). Cardiovasc Diabetol. 2017;16(1):126. https://doi.org/10.1186/s12933-017-0609-4 A retrospective nationwide register-based study in Spain examining the trends in number of cases and outcomes, in-hospital mortality, and length of hospital stay for major cardiovascular events in individuals with type 2 diabetes compared with non-diabetics.

    Article  PubMed  PubMed Central  Google Scholar 

  33. U.S. Food and Drug Administration. Guidance for industry: diabetes mellitus - evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. In: Fda.gov; 2018. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071627.pdf. Accessed 31 Oct 2018

    Google Scholar 

  34. Azimova K, San Juan Z, Mukherjee D. Cardiovascular safety profile of currently available diabetic drugs. Ochsner J. 2014 Winter;14(4):616–32.

    PubMed  PubMed Central  Google Scholar 

  35. •• Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311–22. https://doi.org/10.1056/NEJMoa1603827 A randomized controlled trial assessing long-term effects of liraglutide on cardiovascular outcomes in individuals with type 2 diabetes.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. • Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Kober LV, et al. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med. 2015;373(23):2247–57. https://doi.org/10.1056/NEJMoa1509225 A randomized controlled trial assessing the effects of lixisenatide on cardiovascular outcomes in individuals with type 2 diabetes who had had a recent acute coronary event.

    Article  CAS  PubMed  Google Scholar 

  37. • Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117–28. https://doi.org/10.1056/NEJMoa1504720 A randomized controlled trial assessing effects of empagliflozin on cardiovascular morbidity and mortality in individuals with type 2 diabetes at high cardiovascular risk.

    Article  CAS  PubMed  Google Scholar 

  38. •• Saad M, Mahmoud AN, Elgendy IY, Abuzaid A, Barakat AF, Elgendy AY, et al. Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors in patients with type II diabetes mellitus: a meta-analysis of placebo-controlled randomized trials. Int J Cardiol. 2017;228:352–8. https://doi.org/10.1016/j.ijcard.2016.11.181 A meta-analysis of randomized controlled trials assessing the effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in individuals with type 2 diabetes.

    Article  PubMed  Google Scholar 

  39. •• American Diabetes Association: 9. Cardiovascular disease and risk management: standards of medical care in diabetes-2018. Diabetes care. 2018;41(Suppl 1):S86-s104. https://doi.org/10.2337/dc18-S009. The American Diabetes Association’s standards of medical care in diabetes related to cardiovascular risk reduction.

Download references

Author information

Authors and Affiliations

  1. Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, 5001 El Paso Drive, MSC 21009, El Paso, TX, 79905, USA

    Thwe Htay, Arianna Lopez-Perez, Amy HoangAnh Doan, Michael A. Romagosa & KoKo Aung

  2. University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA

    Kyaw Soe

Authors
  1. Thwe Htay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyaw Soe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arianna Lopez-Perez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amy HoangAnh Doan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael A. Romagosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. KoKo Aung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thwe Htay.

Ethics declarations

Conflict of Interest

Thwe Htay, Kyaw Soe, Arianna Lopez-Perez, Amy HoangAnh Doan, Michael A. Romagosa, and KoKo Aung declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Ischemic Heart Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Htay, T., Soe, K., Lopez-Perez, A. et al. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. Curr Cardiol Rep 21, 45 (2019). https://doi.org/10.1007/s11886-019-1133-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-019-1133-9

Keywords

Search

Navigation